SITHANDIWE MAMUTSE: Open Payments
NPI 1942820444 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,245 in 151 payments from 17 companies in 2025. Trend: 2023 $3,192 · 2024 $3,599 · 2025 $3,245
Food & beverage: $3,237Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $451 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $423 |
| Otsuka America Pharmaceutical, Inc. | 20 | $366 |
| Lundbeck LLC | 16 | $301 |
| Axsome Therapeutics, Inc. | 8 | $301 |
| Janssen Pharmaceuticals, Inc | 9 | $289 |
| Teva Pharmaceuticals USA, Inc. | 8 | $244 |
| Alkermes, Inc. | 6 | $173 |
| Neurocrine BioSciences, Inc. | 10 | $172 |
| Supernus Pharmaceuticals, Inc. | 15 | $153 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, INVEGA SUSTENNA, AUSTEDO XR, ABILIFY MAINTENA, ARISTADA.
Industry payments across KY — which companies pay providers there.
